Rarer-yet-serious GLP-1 risks While rarer than the above side effects, there are some serious issues that could arise if youre taking a GLP-1
Theres also a noted risk for thyroid cancer
With patent expiries and rising political pressure on drug pricing, the next two years could reshape who gets to benefit from this new era of metabolic medicine.For now, if you are curious about these drugs, talk to your clinician, check coverage options and weigh both the potential benefits and the long-term cost before deciding
Finally, the FLOW trial may shed further light on the potential mechanisms involved on how GLP-1 receptor agonism could alter renal physiology, combined with future mechanistic studies that aim to find proof for the effects of GLP-1 receptor agonists on the renal risk factors/pathophysiological mechanisms related to DKD as summarized in this review
It enhances the bodys ability to generate fuel from fat, which supports higher energy levels during physical activity
Generally, treatment is well-tolerated